Letermovir

CHEMBL1241951 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

572.5 g/mol

LogP

4.6

Phase

4

This antiviral inhibits CMV terminase complex by a unique mechanism, preventing cytomegalovirus infection after stem cell transplant.

Peso Molecular

572,5000 g/mol

LogP

4,60

TPSA

77,80 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Lymphoma HIV/AIDS Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cccc(N2CCN(C3=Nc4c(F)cccc4[C@H](CC(=O)O)N3c3cc(C(F)(F)F)ccc3OC)CC2)c1

InChI

InChI=1S/C29H28F4N4O4/c1-40-20-6-3-5-19(16-20)35-11-13-36(14-12-35)28-34-27-21(7-4-8-22(27)30)23(17-26(38)39)37(28)24-15-18(29(31,32)33)9-10-25(24)41-2/h3-10,15-16,23H,11-14,17H2,1-2H3,(H,38,39)/t23-/m0/s1

Molecular Formula

C29H28F4N4O4

HBD / HBA

1 / 10

Ligações Rotacionáveis

7

Átomos Pesados

41

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This antiviral inhibits CMV terminase complex by a unique mechanism, preventing cytomegalovirus infection after stem cell transplant.

Yes, Letermovir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1241951. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 45138674. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Letermovir no PillFYI

Estrutura

Dados Rápidos

Fórmula: C29H28F4N4O4
Sinônimos: 1

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.